Moderna will accelerate its investment in Shanghai
PHOTO
Moderna has registered a biotech firm in China's financial hub Shanghai with capital of $100 million, according to Chinese data providers including company database Qichacha.
Moderna will accelerate its investment in Shanghai and work with Chinese partners on local research, development and production, local media YiCai Global reported last month, citing the chief executive of the U.S. biotech firm. (Reporting by Beijing newsroom; editing by Jason Neely)
Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.
© ZAWYA 2024
